Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Retained Earnings (2021 - 2025)

Roivant Sciences (ROIV) has disclosed Retained Earnings for 5 consecutive years, with -$695.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings fell 8726.04% year-over-year to -$695.0 million, compared with a TTM value of -$695.0 million through Dec 2025, down 8726.04%, and an annual FY2025 reading of $9.4 million, down 98.36% over the prior year.
  • Retained Earnings was -$695.0 million for Q4 2025 at Roivant Sciences, down from $19.6 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $576.2 million in Q1 2024 and bottomed at -$4.4 billion in Q3 2023.
  • Average Retained Earnings over 5 years is -$1.0 billion, with a median of -$18.0 million recorded in 2024.
  • The sharpest move saw Retained Earnings tumbled 345694.39% in 2022, then soared 22116.51% in 2024.
  • Year by year, Retained Earnings stood at -$1.1 million in 2021, then crashed by 345694.39% to -$3.7 billion in 2022, then skyrocketed by 99.25% to -$27.8 million in 2023, then soared by 129.0% to $8.1 million in 2024, then plummeted by 8726.04% to -$695.0 million in 2025.
  • Business Quant data shows Retained Earnings for ROIV at -$695.0 million in Q4 2025, $19.6 million in Q3 2025, and -$315.6 million in Q2 2025.